Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Xinhualian Pharmaceutical is a specialized pharmaceutical company based in China, primarily focused on the development and manufacturing of steroid hormone APIs and finished drug products. Originally established as the Shanghai No. 3 Pharmaceutical Factory, the company has a long history in the production of corticosteroids and reproductive health medications. It operates as a key manufacturing subsidiary under Shanghai Pharmaceuticals Holding Co., Ltd. (Shanghai Pharma). The company's portfolio includes widely used treatments such as dexamethasone, prednisone, and mifepristone. Shanghai Xinhualian maintains significant manufacturing capabilities with GMP-certified facilities serving both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Xinhualian Pharmaceutical.